US CDC Reports 36 H5 Bird Flu Cases In U.S. Since April; Six Cases In Washington Poultry Workers Confirmed Last Week; No Person-To-Person Spread Detected; Public Risk Remains Low But Higher For Those Exposed To Infected Animals; 15 Cases Linked To...
It's Time to Get Your Covid and Flu Shots. Everything to Know About This Year's Vaccines. -- Barrons.com
The Market Doesn't Like What It Sees From Novavax, Inc.'s (NASDAQ:NVAX) Revenues Yet As Shares Tumble 25%
Express News | Novavax Inc: U.S. Cdc and Acip Recommend Additional Covid-19 Vaccine Dose for Older Individuals and Those Who Are Immunocompromised
CDC Issues Report On Missouri H5N1 Serology Testing; Confirms No Human-To-Human Transmission Of H5 Bird Flu Detected In US
U.S. CDC and ACIP Recommend Additional COVID-19 Vaccine Dose for Older Individuals and Those Who Are Immunocompromised
Is Trending Stock Novavax, Inc. (NVAX) a Buy Now?
How Bad Is This News for Novavax?
Express News | EMA: Chmp Gave Positive Opinions to Update Composition of Nuvaxovid and Bimervax
Novavax (NVAX) Advances While Market Declines: Some Information for Investors
Novavax Stock Plummets as FDA Pauses Clinical Trial on Safety Concerns -- Barrons.com
Novavax Stock Falls After FDA Puts Two Vaccine Programs on Hold
Novavax Reports FDA Placed Clinical Hold on IND for COVID-flu Combo Vaccine
J.P. Morgan Maintains Novavax(NVAX.US) With Sell Rating, Maintains Target Price $9
Novavax's Regulatory Setback and Mid-Term Underperformance: An Analyst's Perspective
Robinhood, Novavax, Phunware, Lucid Group, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
Novavax pharmaceuticals plunged 20% as the US FDA paused its COVID/Influenza combination vaccine trial.
①After a severe motor neuron disorder event occurred in one of the study participants, the Food and Drug Administration (FDA) of the united states suspended the company's clinical trial of 'Influenza/COVID-19 combination vaccine'; ②Novavax claims that it is working with the FDA to resolve the clinical hold issue of its combination vaccine and separate influenza vaccine trials.
Novavax Analyst Ratings
Jefferies Maintains Novavax(NVAX.US) With Buy Rating, Cuts Target Price to $25
Cautious Optimism for Novavax Amid Clinical Hold Challenges